Pharmanumbers Home
What's New:
March 1, 2012
Latest Article
Pharma Revolution Recalibrated, Pharmaceutical Executive, November 2011
Bionumbers Index
May 2, 2012
All Indexes Updated - End April 2012
It was a downer for all indexes and the NASDAQ, except the CSPI. The drop in the NASDAQ seemed to be related to some profit taking while the drop in the Emerging Specialty and Drug Delivery indexes was related to bad development/regulatory news for a couple of the larger companies in the index. Check out the index details for more numbers.
Welcome to The Pharmanumbers Goup
We are Drug Delivery specialists with a focus on understanding new products and markets to ensure an optimal fit. Our services range from consulting and resource help (Pharmanumbers), to industry analysis and reports (Bionumbers).
Pharmanumbers
Pharmanumbers provides companies with consulting and resource help. Our clients cover the full spectrum of biopharma companies, from start-ups to companies that are commercially successful and profitable. We provide hands on support and resources in the areas of business and corporate development, with a focus on new product planning, sales and profitability forecasting, as well as deal term development and evaluation.
Bionumbers
Bionumbers prepares industry analyses and reports that go beyond the expected to uncover the key parameters and factors impacting product development success and prfitability. Our most recent report DDEP2011, analyzes the Drug Delivery business from the perspective of pipeline success rates, clinical development times and a number of commercial sucess parameters such as sales, prescriptions, and market exclusivity periods. These are the numbers that companies and investors need to understand if they hope to develop profitable new products that meet budgets and timelines.
Looking for the Bionumbers Market Cap Index? You can find it at the Bionumbers Index tab.
